How Dexcom Won the Consumer CGM Market

Episode 30 of The Digital Health Podcast with Fexingo dives into how Dexcom turned continuous glucose monitoring from a niche diabetes tool into a mainstream wellness product. Lucas and Luna break down the key strategic moves Dexcom made to pull ahead of Abbott's FreeStyle Libre: the G7 sensor's smaller design, the decision to go direct-to-consumer with over-the-counter sales, and the controversial move to launch 'Dexcom Stelo' for non-diabetic health optimizers. They discuss the market numbers—Dexcom's 38% revenue growth in 2025 versus Abbott's 12% in diabetes care—and what the FDA's loosening of prescription requirements means for the future of wearable diagnostics. If you're in digital health or just watching where the smartwatch replacement cycle goes, this episode gives you the specific competitive dynamics shaping the CGM duopoly. #Dexcom #CGM #ContinuousGlucoseMonitor #AbbottFreeStyleLibre #DiabetesTech #DigitalHealth #Wearables #HealthTech #FDA #OverTheCounter #DexcomStelo #GlucoseMonitoring #WellnessTech #Business #Technology #FexingoBusiness #BusinessPodcast #HealthInnovation Keep every episode free: buymeacoffee.com/fexingo